The Latest Breaking News from the US Food and Drug Administration

An advisory panel of the US Food and Drug Administration has found that a drug used in the majority of cold and flu products to treat blocked noses does not work.

The study represents the first long-term, large-scale, real-world trial of the blockbuster drug, researchers said.

With measures to protect abortion access becoming law in two states, a ban in a third state and court action elsewhere, the status of abortion law in the U.S. remains unsettled

The Vermont Legislature has passed reproductive and gender-affirming health care bills with a late addition aimed at protecting access to a medication widely used in abortions — even if the U.S. Food and Drug Administration withdraws its approval of mifepristone

Political pressure is nothing new for the U.S. Food and Drug Administration. The agency has frequently come under fire for its drug approval decisions, but attacks on its decision-making process and science itself have increased during the COVID-19 pandemic.

After years of robust growth, the biotech industry has struggled since last year due to several headwinds, including regulatory concerns, inflation, and the Fed’s aggressive rate hikes, which have sucked out speculative capital. Despite currently being one of the poorly-rated industries, investors could consider buying top-biotech stocks Gilead (GILD), Vertex…